Tag:
National Institutes of Health
Latest Headlines
Latest Headlines
Sanofi teams with Big Data outfit to research drugs for diabetes and cancer
Sanofi research czar Elias Zerhouni has pushed for the company to delve deeply into the study of diseases before leaping into drug development. Now the French drug giant plans to collaborate with the software company NextBio to infuse patients' genomic and other data into its work on treatments for such diseases as cancer and diabetes.
NIH stops HIV vaccine trial after immunizations fail
The federal government has put the brakes on the largest and most advanced study of a vaccine against HIV infection after an independent data and safety monitoring board found that the vaccine regimen did not benefit patients.
Mount Sinai wins $5M to study vocal disorder biomarkers
A researcher at the Icahn School of Medicine at Mount Sinai has won a $5 million grant from the National Institutes of Health to investigate diagnostic biomarkers of spasmodic dysphonia, a rare neurological disorder that affects the vocal chords.
Obama administration plans brain-mapping project
President Barack Obama is poised to launch a public-private initiative aimed at mapping the human brain, called the Brain Activity Map.
Sanofi launches 'talking' emergency epinephrine injector
The prescription Auvi-Q injection device, now available in the U.S. from Sanofi, provides step-by-step instructions for the user that include audible and visual cues and an injection countdown.
NIH launches online collaborative to find Parkinson's biomarkers
In the latest push to better predict, diagnose and monitor Parkinson's disease, the National Institute of Neurological Disorders and Stroke, part of NIH, is launching a new online collaborative resource that will support data-sharing in an effort to find biomarkers for the disease.
Gene discovery could change treatment for hepatitis C
Scientists at the National Cancer Institute, part of the National Institutes of Health, have developed a new gene that interferes with the clearance of hepatitis C infection.
NIH finds another piece in Alzheimer's risk puzzle
The complement receptor-1 (CR1) gene has recently been linked with the risk of late-onset Alzheimer's disease. Researchers from the National Institute on Aging (NIA) at the National Institutes of Health have found that a variant in the gene affects the levels of beta amyloid in the brains of cognitively healthy older people.
FDA seeks ways to boost antibacterial drug pipeline
While it is not mentioned in the announcement, the drug-resistant superbug that has now killed 7 people infected at the National Institutes of Health Clinical Center had to be on the mind of FDA officials when they decided to form a task force to help push antibacterial drug development.
Protein finding points to Parkinson's blood test
Researchers from Columbia University Medical Center (CUMC) have found potential biomarkers and drug targets for the more common, non-inherited form of Parkinson's disease.
